日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity

EZH2与DNA甲基化之间的相互作用介导神经内分泌前列腺癌谱系可塑性

Singh, Richa; Venkadakrishnan, Varadha Balaji; Imada, Eddie; Yamada, Yasutaka; Brady, Nicholas J; Dunmore, Kate E; Garner, Richard; Booker, Matthew A; Hanratty, Brian; Haffner, Michael C; Tolstorukov, Michael Y; Marchionni, Luigi; Robinson, Brian D; Rickman, David S; Beltran, Himisha

Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers

雄激素受体剪接变体7的表达水平可以区分AR突变型和非突变型转移性去势抵抗性前列腺癌。

Paschalis, Alec; Figueiredo, Ines; Bogdan, Denisa; Lundberg, Arian; Santos, Rita; Gurel, Bora; Taha, Tarek; Longoria, Ossian; Ferreira, Ana; Bertan, Claudia; Brittain, Nicholas; Nelson, Ryan; Walker, Laura; Neeb, Antje; Welti, Jonathan; Yuan, Wei; Mitsopoulos, Costas; Plymate, Stephen R; Haffner, Michael C; Sowalsky, Adam G; Carreira, Suzanne; Sharp, Adam; Gaughan, Luke; de Bono, Johann

Phenotypic discovery and therapeutic evaluation of an ITGA3B1-targeting antibody-drug conjugate for bladder cancer

ITGA3B1靶向抗体药物偶联物在膀胱癌中的表型发现和治疗评价

Lee, Junghyeon; Jung, Hyeryeon; Kim, Eunhee G; Ahn, Jinsung; Haffner, Michael C; Nelson, Peter S; Kim, Kwang Pyo; Lee, John K; Yi, Eugene C; Kim, Kristine M

OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance.

OGDHL促进前列腺癌进展,并调节神经内分泌标志物表达和核苷酸丰度。

Bernard Matthew J, Gallardo Andrea, Ruiz Angel, Diaz Johnny A, Nunley Nicholas M, Dove Rachel N, Zhang Shile, Lee Ernie, Heering Kylie Y, Varuzhanyan Grigor, Bopardikar Sachi, Hashimoto Takao, Agrawal Raag, Smith Chad M, Wilde Blake R, Matulionis Nedas, Richards Helen M, Lee Sandy Che-Eun S, Sharifi Marina N, Lang Joshua M, Zhao Shuang G, Witte Owen N, Haffner Michael C, Shackelford David B, Boutros Paul C, Christofk Heather R, Goldstein Andrew S

Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies.

确定阿克拉霉素在儿童恶性肿瘤中的临床前安全性。

Tu Darleen S, Olson Aaron K, Waggie Kimberly S, Garcia Nicolas M, Hoglund Virginia J, Walter Stephanie I, Rosinski Jenna R, Sadeeshkumar Harini, Patel Radhika, Sayar Erolcan, Haffner Michael C, Maves Lisa, Neefjes Jacques, Sarthy Jay F, Lawlor Elizabeth R, Ganapathi Shireen S

Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncology.

基于深度学习的无细胞DNA肿瘤转录组非侵入性分析,用于精准肿瘤学。

Patton Robert D, Netzley Alexander, Persse Thomas W, Nair Akira, Galipeau Patricia C, Coleman Ilsa M, Itagi Pushpa, Chandra Pooja, Adil Mohamed, Vashisth Manasvita, Sayar Erolcan, Hiatt Joseph B, Dumpit Ruth, Kollath Lori, Demirci Ridvan Arda, Ghodsi Alireza, Lam Hung-Ming, Morrissey Colm, Iravani Amir, Chen Delphine L, Hsieh Andrew C, MacPherson David, Haffner Michael C, Nelson Peter S, Ha Gavin

Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer

致命性前列腺癌的肿瘤内和肿瘤间表型异质性模式

Roudier, Martine P; Gulati, Roman; Sayar, Erolcan; Patel, Radhika A; Tratt, Micah; Richards, Helen M; Cejas, Paloma; Munoz Gomez, Miguel; Qiu, Xintao; Xie, Yingtian; Hanratty, Brian; Zaidi, Samir; Zhao, Jimmy L; Adil, Mohamed; Mittal, Chitvan; Zhao, Yibai; Dumpit, Ruth; Coleman, Ilsa; Low, Jin-Yih; Persse, Thomas; Galipeau, Patricia; Lee, John K; Tretiakova, Maria; Chambers, Meagan; Vakar-Lopez, Funda; True, Lawrence D; Perrone, Marie; Lam, Hung-Ming; Kollath, Lori A; Ding, Chien-Kuang Cornelia; Harmon, Stephanie; Cheng, Heather H; Yu, Evan Y; Montgomery, Robert B; Hawley, Jessica E; Lin, Daniel W; Corey, Eva; Schweizer, Michael T; Setty, Manu; Ha, Gavin; Sawyers, Charles L; Morrissey, Colm; Long, Henry; Nelson, Peter S; Haffner, Michael C

PROX1 is an early driver of lineage plasticity in prostate cancer.

PROX1 是前列腺癌谱系可塑性的早期驱动因素

Duan Zhi, Shi Mingchen, Kumaraswamy Anbarasu, Lin Dong, Khokhani Dhruv, Wang Yong, Zhang Chao, Flores Diana, Rodansky Eva, Swaim Olivia A, Storck William K, Beck Hannah N, Patel Radhika A, Sayar Erolcan, Hanratty Brian P, Xue Hui, Dong Xin, Maylin Zoe R, Wan Rensheng, Quigley David A, Sjöström Martin, Hu Ya-Mei, Zhao Faming, Xia Zheng, Cheng Siyuan, Yu Xiuping, Feng Felix Y, Zhang Li, Aggarwal Rahul, Small Eric J, Ravikumar Visweswaran, Rao Arvind, Bedi Karan, Lee John K, Morrissey Colm, Coleman Ilsa, Nelson Peter S, Corey Eva, Udager Aaron M, Rebernick Ryan J, Cieslik Marcin P, Chinnaiyan Arul M, Yates Joel A, Haffner Michael C, Wang Yuzhuo, Alumkal Joshi J

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

转移性去势抵抗性前列腺癌活检病理学检查框架

Haffner, Michael C; Morris, Michael J; Ding, Chien-Kuang C; Sayar, Erolcan; Mehra, Rohit; Robinson, Brian; True, Lawrence D; Gleave, Martin; Lotan, Tamara L; Aggarwal, Rahul; Huang, Jiaoti; Loda, Massimo; Nelson, Peter S; Rubin, Mark A; Beltran, Himisha

Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after (177)Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes

既往 PARP 抑制剂暴露与去势抵抗性前列腺癌患者接受 (177)Lu-PSMA-617 治疗后的临床结果以及 DNA 同源重组修复基因突变之间的关联

Raychaudhuri, Ruben; Tuchayi, Abuzar Moradi; Low, Soon Khai; Arafa, Ali T; Graham, Laura S; Gulati, Roman; Pritchard, Colin C; Montgomery, Robert B; Haffner, Michael C; Nelson, Peter S; Yu, Evan Y; Hawley, Jessica E; Cheng, Heather H; Mo, George; Chen, Delphine L; Antonarakis, Emmanuel S; Kilari, Deepak; Hope, Thomas A; Iravani, Amir; Schweizer, Michael T